Evidence map›Paper›PMID 34367464›Full record

ArticleOxidative medicine and cellular longevity2021

Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency.

Xing-Yu Zhou, Jun Zhang, Ying Li, Ying-Xue Chen, Xiao-Min Wu, Xin Li, Xiao-Fei Zhang, Lin-Zi Ma, Yi-Zhen Yang, Ke-Ming Zheng and 3 more

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xing-Yu ZhouCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.ORCID https://orcid.org/0000-0002-2761-6206
Jun ZhangCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Ying LiCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Ying-Xue ChenCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Xiao-Min WuCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Xin LiCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Xiao-Fei ZhangCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Lin-Zi MaCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Yi-Zhen YangCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Ke-Ming ZhengCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Yu-Dong LiuCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Zhe WangCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.
Shi-Ling ChenCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou 510515, China.ORCID https://orcid.org/0000-0003-4473-5538

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism underlying the role of oxidative stress and advanced oxidation protein products (AOPPs) in the aetiology of premature ovarian insufficiency (POI) is poorly understood. Here, we investigated the plasma AOPP level in POI patients and the effects of AOPPs on granulosa cells both in vitro and in vivo. KGN cells were treated with different AOPP doses, and cell cycle distribution, intracellular reactive oxygen species (ROS), and protein expression levels were measured. Sprague-Dawley (SD) rats were treated daily with PBS, rat serum albumin, AOPP, or AOPP+ N-acetylcysteine (NAC) for 12 weeks to explore the effect of AOPPs on ovarian function. Plasma AOPP concentrations were significantly higher in both POI and biochemical POI patients than in controls and negatively correlated with anti-Müllerian hormone and the antral follicle count. KGN cells treated with AOPP exhibited G1/G0-phase arrest. AOPP induced G1/G0-phase arrest in KGN cells by activating the ROS-c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (MAPK)-p21 pathway. Pretreatment with NAC, SP600125, SB203580, and si-p21 blocked AOPP-induced G1/G0-phase arrest. In SD rats, AOPP treatment increased the proportion of atretic follicles, and NAC attenuated the adverse effects of AOPPs in the ovary. In conclusion, we provide mechanistic evidence that AOPPs may induce cell cycle arrest in granulosa cells via the ROS-JNK/p38 MAPK-p21 pathway and thus may be a novel biomarker of POI.

Indexed as

Cell Cycle CheckpointsAdvanced Oxidation Protein ProductsAnimalsApoptosisCell ProliferationCells, CulturedCyclin-Dependent Kinase Inhibitor p21FemaleG1 PhaseGene Expression RegulationGranulosa CellsHumansJNK Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPrimary Ovarian InsufficiencyPrognosisAdvanced Oxidation Protein ProductsCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21JNK Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesReactive Oxygen Species

Identifiers

PMID34367464
PMCPMC8337115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.